Print side
| Forsiden | Send side | Søg


  1. Abraham AS, Eylath U et al. Serum magnesium levels in patients with acute myocardial infarction. New Eng J Med 296: 862-863, 1977. 
  2. Abraham GE, Flechas JD. Hypothesis: Management of fibromyalgia: rationale for the use of magnesium and malic acid. J Nutr Med 3:49-59, 1992.
  3. Annand JC. Pyridoxine and magnesium in the treatment of shock. Lancet ii: 340-1, 1957.
  4. Berger DS, Reiter WM, Vorce DE, et al. Prevalence of red blood cell magnesium deficiency in HIV-1 infected patients and its association with fatigue and myalgia. Abstract. J Am Coll Nutr 13; 5: 522, 1994.
  5. Brenton DP, Gordon TE. Fluid and electrolyte disorders. Magnesium. Br J Hospital Med 1: 60-69, 1984.
  6. Curry DL et al.:Magnesium modulation of glucose-induced insulin secretion by the perfused rat
  7. pancreas. Endocrinology 101:203, 1977.
  8. Dahle LO, Berg G, Hammar M et al. The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol 1995; 173: 175-180. 
  9. DeLuca HF. The Vitamin D system in the regulation of calcium and phosphorus metabolism. Nutr Rev 1979; 37: 161-193. 
  10. Dreosti, IE. Magnesium status and health. Nutr Rev 1995; 53: S23-S27. 
  11. Dunn MJ, Waber M. Magnesium depletion in normal man. Metabolism 1966; 15: 884-895. 
  12. Eisinger J, Bagneres D, Arroyo P, et al. Effects of magnesium, high energyphosphates, piracetam and thiamin on erythrocyte transketolase. Magnes Res 7(1):59-61, 1994.
  13. Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 394:217-23, 1995. 
  14. Fletcher MP, Gershwin ME, Keen CL et al. Trace element deficiences and immune responsiveness in humans and animal models. In: Chandra RJ, ed. Nutrition and immunology. New York: Alan R. Liss. 1988: p 215-239. 
  15. Hallson PG, Rose G, Sulaiman SM. Magnesium reduces calcium oxalate crystal formahon in human whole unne. Clin Sci 62: 17-19, 1982.
  16. Hodgkinson A, Marshall DH, Nordin BEC. Vitamin D and magncsium absorption in man. Clin Sci 1979; 57: 121-123. 
  17. Howard JMH. Magnesium deficiency in peripheral vascular disease. J Nutr Med 1990; 1: 39-49. 
  18. Johansson G et al. Biochemical and clinical effects of prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 124; 6:770-4, 1980.
  19. Johansson G, Backman U, Danielson B et al. Magnesium metabolism in renal stone formers. Effects of therapy with magnesium hydroxide. Scand J Urol Nephrol 53: 125-130, 1980.
  20. Johansson G. Magnesium and renal stone disease. Acta Med Scand; suppl 661:13-18, 1982
  21. Johansson G et al. Effects of magnesium hydroxide in renal stone disease. J Am Coll Nutr 1, 2:179-85, 1982.
  22. Jones JE, Manalo R, Flink EB et al. Magnesium requirements in adults. Am J Clin Nutr 1967; 20: 632. 
  23. Laban E, Chardon GA. Magnesium and cardiac arrhythmias. Nutrient or drug? J Am Coll Nutr 1986; 5: 521-532. 
  24. Lemke, MR. Plasma magnesium decrease and altered calcium/magnesium ratior in severe dementia of the Alzheimer typc. Biol Psychiatry 1995; 37: 341-343. 
  25. Lindberg J, Harvey J, Pak CYC. Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction. J Urol 143; 2:248-51, 1990.
  26. Lyon E, Borden T, Ellis J, Vermeulen C. Calcium oxalate lithiasis produced by pyridoxine deficiency and inhibition with high magnesium diets. Invest Urol 4: 133-142, 1966.
  27. Posacki C, et al. Plasma, Copper, Zinc, and Magnesium Levels in Patients with Premenstrual Tension Syndrome, Acta syndrome : Obstet Gynecol Scand 73; 452-5, 1994.
  28. Prien EL, Gershoff S. Magnesium oxide-pyridoxine therapy for recurring calcium oxalate urinary calculi. J Urol 112:509-512, 1974.
  29. Rattan VF, Sidhu H, Vaidyanathan S, et al. Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers. Urol Res 22; 3:161-5, 1994.
  30. Resnick LM, Gupta RK, Laragh JH. Intracellular free magnesium to erythrocytes of essential hypertension. Relation to blood pressure and serum divalent cations. Proc Nat Aca Sci 1984 81: 6511-6515. 
  31. Romano TJ, Stiller JW. Magnesium deficiency in fibromyalgia syndrome. J Nutr Med 4:165-7, 1994.
  32. Romano TJ. Magnesium deficiency in systemic lupus erythematosus. J Nutr Environ Med 7: 107-11, 1997.
  33. Rude RK, Olerich Ml. Magnesium deficiency: Possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteoporosis Int 6; (6):453-61, 1996.
  34. Rushton H, Spector M. Effects of magnesium deficiency on intra tubular calcium oxalate formation and crystalluria in hyperoxaluric rats. J Urol 127: 598-604, 1982.
  35. Seelig MS. The requirement of magnesium by the normal adult. Am J Clin Nutr 14: 342-390, 1964. 
  36. Seelig MS, Heggtveit H. Magnesium interrelationships in ischemic heart disease. Am J Clin Nutr 27: 59-79, 1974. 
  37. Seelig MS. Magnesium in oncogenesis and in anti-cancer treatment interaction with minerals and vitamins. In: Ouillian, P, Williams, RM, eds. Adjucant nutrition in cancer treatment. Publ Cancer Treatment Res Foundation, 15: 238-318, 1993. 
  38. Schmiedl A, Schwille P. Magnesium status in idiopathic calcium urolithiasis – An orientational study in younger males. Eur J Clin Chem Clin Biochem 34:393-40, 1996.
  39. Sheehan JP, Seelig MS. Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease. Magnesium 3: 301-314, 1984.
  40. Shils, ME. Magnesium. In: Present knowledge in nutrition. 7th edn. Washington, DC: Nutrition Foundation. 1996: p 256-264. 
  41. Shils ME. Experimental human magnesium depletion. Medicine 1969; 48: 61-85. 
  42. Shils ME. Experimental human magnesium depletion. I. Clinical observations and blood chemistry alterations. Am J Clin Nutr 1964; 15: 133-143. 
  43. Shine Kl. Myocardial effects of magnesium. Am J Physiol 1979; 237: H413-H423. 
  44. Singh RB, Cameron EA. Relation of myocardial magnesium deficiency to sudden death in ischemic heart disease. Am Heart J 1982; 103: 399-450. 
  45. Sjogren A, Edvinsson L, Fallgren B. Magnesium deficiency in coronary artery diseases and cardiac arrhythmias. J Int Med 1989; 226: 213-222. 
  46. Takahasi E. The magnesium:calcium ratio in the concentrated urines of patients with calcium oxalate calculi. Invest Urol 10:147, 1972.
  47. Tucker MM, Turco SJ. Human nutrition. Philadelphia: Lea & Febiger. 1983: p 25-28. 
  48. Wacker WEC, Parisi AF. Magnesium metabolism. N Eng J Med 1968; 278: 658-663, 712-717, 772-786. 
  49. Watson WS, Lyon TDB, Hilditch TE. Red cell magnesium as a function of cell age. Metabol Clin Exp 1980; 29: 397-399. 
  50. White JR et al. Magnesium and Diabetes: A Review. Ann Pharmacother 27: 775-80, 1993.
  51. Wunderlich W. Aspects of the influence of magnesium ions on the formation of calcium oxalate. Urol Res 1981; 9: 157-160.



Joseph E. Pizzorno Jr., Michael T. Murrey & Melvyn R. Werbach.